Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
Bone Metastases
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Precision Medicine in Oncology
®
Sarcomas
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
Ovarian Cancer
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
More >>
Ovarian Cancer Videos
Dr. Eskander on Need for Biomarkers in Ovarian Cancer
Ramez N. Eskander, MD, assistant clinical professor, Department of Reproductive Medicine, University of California, San Diego Moores Cancer Center, discusses the need for more effective biomarkers in the treatment of patients with ovarian cancer.
Onclive TV
>
Dr. Karam on the Use of Laparoscopy in Advanced Ovarian Cancer
Amer Karam, MD, associate clinical professor of Gynecologic Oncology at Stanford Hospital and director of Robotic Surgery and Outreach in the Division of Gynecologic Oncology at Stanford Medicine, discusses the use of laparoscopy in advanced ovarian cancer.
Onclive TV
>
Dr. Grisham on Frontline Treatment for Low-Grade Serous Ovarian Cancer
Rachel N. Grisham, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses frontline treatment options for patients with low-grade serous ovarian cancer.
Onclive TV
>
Dr. Eskander on Combination Approaches With Immunotherapy in Ovarian Cancer
Ramez N. Eskander, MD, assistant clinical professor, Department of Reproductive Medicine, University of California, San Diego Moores Cancer Center, discusses combination approaches with immunotherapy in ovarian cancer.
Onclive TV
>
Dr. English on an Investigational Antibody-Drug Conjugate in Ovarian Cancer
Diana P. English, MD, a gynecologic oncologist at Stanford Hospital and Clinics, discusses an investigational antibody-drug conjugate (ADC) in ovarian cancer.
Onclive TV
>
Dr. Horowitz on Frontline Strategies in Newly Diagnosed Ovarian Cancer
Neil Horowitz, MD, director of Clinical Research in Gynecologic Oncology, associate professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Dana-Farber Cancer Institute, discusses frontline strategies in the treatment of patients with newly diagnosed advanced ovarian cancer.
Onclive TV
>
Dr. Coleman on Advances Made in Ovarian Cancer Treatment
Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses advances made in the treatment of ovarian cancer.
Conference Coverage
>
2019 SGO Winter Meeting
Dr. Kurnit on Adjuvant Chemotherapy Regimens in Mucinous Ovarian Cancer
Katherine Kurnit, MD, OBGYN oncology fellow at the University of Texas MD Anderson Cancer Center, compares the benefit of gastrointestinal-based versus gynecologic-based adjuvant chemotherapy regimens in patients with mucinous ovarian cancer.
Conference Coverage
>
2019 SGO Winter Meeting
Dr. Westin on Advances Made With PARP Inhibitors in Ovarian Cancer
Shannon N. Westin, MD, MPH, associate professor, The University of Texas MD Anderson Cancer Center, discusses advances made with PARP inhibitors in the ovarian cancer treatment paradigm.
Conference Coverage
>
2019 SGO Winter Meeting
Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian Cancer
Panagiotis A. Konstantinopoulos, MD, director, Translational Research, Gynecologic Oncology, Dana-Farber Cancer Institute, associate professor of medicine, Harvard Medical School, discusses the disappointing results of the JAVELIN 200 trial in ovarian cancer.
Onclive TV
>
Next Page >>
FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More
Trending Now
Novel CLL Regimens Show Promising Efficacy
FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma
FDA Grants Pembrolizumab Priority Review for Advanced SCLC
FDA Grants Entrectinib Priority Review for NTRK+ Tumors and ROS1+ NSCLC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x